Anti-inflammatory potential of a malleable matrix composed of fermented whey proteins and lactic acid bacteria in an atopic dermatitis model

Journal of Inflammation

Volumn 4, Issue , 2007, Pages

  Beaulieu, Josée ^a,b   Dupont, Claude ^a   Lemieux, Pierre ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Technologie Biolactis   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HYDROCORTISONE; MALLEABLE PROTEIN MATRIX; MYELOPEROXIDASE; OXAZOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; FEMALE; FERMENTATION; IN VITRO STUDY; LACTIC ACID BACTERIUM; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OTITIS; POLYMORPHONUCLEAR CELL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

MUS;

EID: 34047094905     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-4-6     Document Type: Article

References (50)

1. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. A Oeser CP Chung Y Asanuma I Avalos CM Stein, Arthritis Rheum 2005 52 3651 3659 10.1002/art.21400 16258902
2. The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. S Toker A Shirom I Shapira S Berliner S Melamed, J Occup Health Psychol 2005 10 344 362 10.1037/1076-8998.10.4.344 16248685
3. Physical activity and modulation of systemic low-level inflammation. H Bruunsgaard, J Leukoc Biol 2005 78 819 835 10.1189/jlb.0505247 16033812
4. The immune system: a target for functional foods? PC Calder S Kew, British Journal of Nutrition 2002 88 S165 S176 10.1079/BJN2002682 12495459
5. Whey proteins and peptides: beneficial effects on immune health. J Beaulieu C Dupont P Lemieux, Therapy 2006 3 1 10 10.1586/14750708.3.1.69
6. Inventing probiotic functional foods for patients with allergic disease. K Laiho A Ouwehand S Salminen E Isolauri, Ann Allergy Asthma Immunol 2002 89 75 82 12487210
7. The biological activity of undenatured dietary whey proteins: role of glutathione. G Bounous P Gold, Clin Invest Med 1991 14 296 309 1782728
8. Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. KD Kent WJ Harper JA Bomser, Toxicol In Vitro 2003 17 27 33 10.1016/S0887-2333(02)00119-4 12537959
9. Lactoferrin and host defense. PP Ward S Uribe-Luna OM Conneely, Biochem Cell Biol 2002 80 95 102 10.1139/o01-214 11908649
10. Oral administration of milk fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1037R-1 to DBA/1 mice inhibits secretion of proinflammatory cytokines. H Kano O Mogami M Uchida, Cytotechnology 2002 40 67 73 10.1023/A:1023966121989
11. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. I Kimber M Cumberbatch RJ Dearman DR Headon M Bhushan CE Griffiths, Biochem Cell Biol 2002 80 103 107 10.1139/o01-227 11911118
12. Modulation of immune function by a modified bovine whey protein concentrate. ML Cross HS Gill, Immunol Cell Biol 1999 77 345 350 10.1046/j.1440-1711.1999.00834.x 10457202
13. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. H Miyauchi S Hashimoto M Nakajima I Shinoda Y Fukuwatari H Hayasawa, Cell Immunol 1998 187 34 37 10.1006/cimm.1997.1246 9682001
14. Effects of tripeptides derived from milk proteins on polymorphonuclear oxidative and phosphoinositide metabolisms. D Migliore-Samour M Roch-Arveiller M Tissot M Jazziri K Keddad JP Giroud P Jolles, Biochem Pharmacol 1992 44 673 680 10.1016/0006-2952(92)90402-5 1324681
15. Immunostimulatory potential of beta-lactoglobulin preparations: Effects caused by endotoxin contamination. S Brix L Bovetto R Fritsche V Barkholt H Frokiaer, Journal of Allergy and Clinical Immunology 2003 112 1216 1222 10.1016/j.jaci.2003.08.047
16. Immunomodulatory effects of dietary whey proteins in mice. CW Wong DL Watson, J Dairy Res 1995 62 359 368 7601980
17. Immunoregulatory peptides in bovine milk. HS Gill F Doull KJ Rutherfurd ML Cross, Br J Nutr 2000 84 Suppl 1 S111 117 11242455
18. Differential effect of dietary protein type on the B-cell and T-cell immune responses in mice. G Bounous PA Kongshavn, J Nutr 1985 115 1403 1408 3877153
19. Multimeric alpha-lactalbumin from human milk induces apoptosis through a direct effect on cell nuclei. A Hakansson J Andreasson B Zhivotovsky D Karpman S Orrenius C Svanborg, Exp Cell Res 1999 246 451 460 10.1006/excr.1998.4265 9925761
20. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. C Matar JC Valdez M Medina M Rachid G Perdigon, J Dairy Res 2001 68 601 609 10.1017/S0022029901005143 11928956
21. Biodefense properties of milk: The role of antimicrobial proteins and peptides. DA Clare GL Catignani HE Swaisgood, Current Pharmaceutical Design 2003 9 1239 1255 10.2174/1381612033454874 12769734
22. Lactic acid bacteria of foods and their current taxonomy. ME Stiles WH Holzapfel, International Journal of Food Microbiology 1997 36 1 29 10.1016/S0168-1605(96)01233-0 9168311
23. Probiotics: an overview of beneficial effects. AC Ouwehand S Salminen E Isolauri, Antonie Van Leeuwenhoek 2002 82 279 289 10.1023/A:1020620607611 12369194
24. Immunobiotics and the probiotic evolution. R Clancy, FEMS Immunology and Medical Microbiology 2003 38 9 12 10.1016/S0928-8244(03)00147-0
25. Probiotic immunomodulation in health and disease. KL Erickson NE Hubbard, J Nutr 2000 130 403S 409S 10721915
26. Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbrueckii ssp. bulgaricus NIAI B6. H Kitazawa H Watanabe T Shimosato Y Kawai T Itoh T Saito, Int J Food Microbiol 2003 85 11 21 10.1016/S0168-1605(02)00477-4 12810267
27. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. L Chapat K Chemin B Dubois R Bourdet-Sicard D Kaiserlian, Eur J Immunol 2004 34 2520 2528 10.1002/eji.200425139 15307184
28. Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. ML Cross RR Mortensen J Kudsk HS Gill, Med Microbiol Immunol (Berl) 2002 191 49 53 10.1007/s00430-002-0112-7
29. Prophylactic and therapeutics uses of probiotics : a review. L Kopp-Hoolohan, Journal of american diet association 2001 101 229 238 10.1016/S0002-8223(01)00060-8
30. Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide. S Reddy M Young S Ginn, Histochem J 2001 33 317 327 10.1023/A:1012422821187 11758808
31. Effect of antioxidative vitamins on immune function with clinical applications. RF Grimble, Int J Vitam Nutr Res 1997 67 312 320 9350472
32. Immunologic effects of yogurt. SN Meydani WK Ha, Am J Clin Nutr 2000 71 861 872 10731490
33. Malleable protein matrix and uses thereof. E Simard D Pilote C Dupont N Lajoie M Quet P Lemieux P Goyette, United States Patent #60/341 2001
34. Immunomodulatory potential of a malleable matrix composed of fermented whey proteins and lactic acid bacteria. J Beaulieu R Dubuc N Beaudet J-F Lapointe C Dupont P Lemieux, J Med Food 2006
35. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. S Grabbe T Schwarz, Immunol Today 1998 19 37 44 10.1016/S0167-5699(97)01186-9 9465487
36. The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. N Romani G Schuler, Springer Semin Immunopathol 1992 13 265 279 10.1007/BF00200527 1411898
37. Dendritic cells: antigen presentation, accessory function and clinical relevance. RM Steinman M Witmer-Pack K Inaba, Adv Exp Med Biol 1993 329 1 9 8379358
38. The skin immune system: progress in cutaneous biology. JD Bos ML Kapsenberg, Immunol Today 1993 14 75 78 10.1016/0167-5699(93)90062-P 8447935
39. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells. C Desvignes N Etchart J Kehren I Akiba JF Nicolas D Kaiserlian, J Immunol 2000 164 2515 2522 10679089
40. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. B Dubois L Chapat A Goubier M Papiernik JF Nicolas D Kaiserlian, Blood 2003 102 3295 3301 10.1182/blood-2003-03-0727 12855551
41. Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. JL Garrigue JF Nicolas R Fraginals C Benezra H Bour D Schmitt, Contact Dermatitis 1994 30 231 237 10.1111/j.1600-0536.1994.tb00650.x 8033550
42. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. PP Bradley DA Priebat RD Christensen G Rothstein, J Invest Dermatol 1982 78 206 209 10.1111/1523-1747.ep12506462 6276474
43. Measurement of myeloperoxidase in leukocyte-containing tissues. Y Xia JL Zweier, Anal Biochem 1997 245 93 96 10.1006/abio.1996.9940 9025973
44. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. LA Merlino J Curtis TR Mikuls JR Cerhan LA Criswell KG Saag, Arthritis Rheum 2004 50 72 77 10.1002/art.11434 14730601
45. An overview of the functionality of exopolysaccharides produced by lactic acid bacteria. P Ruas-Madiedo J Hugenholtz P Zoon, International Dairy journal 2002 12 163 171 10.1016/S0958-6946(01)00160-1
46. Sensitization versus elicitation in allergic contact dermatitis: potential differences at cellular and molecular levels. H Xu B Bjarnason CA Elmets, Am J Contact Dermat 2000 11 228 234 10.1053/ajcd.2000.8009 11123416
47. The pharmacological modulation of delayed type hypersensitivity (DTH) reactions to topical oxazolone in mouse skin. D Cavey M Bouclier G Burg F Delamadeleine CN Hensby, Agents Actions 1990 29 65 67 10.1007/BF01964723 2158222
48. Adrenocorticotropic hormone and adrenal steroids. H Kalant WHE Roschlau, Principles of medical pharmacology Toronto, Decker BC, 1989 474 482
49. Neutrophilic dermatoses. JP Callen, Dermatol Clin 2002 20 409 419 10.1016/S0733-8635(02)00006-2 12170875
50. Inflammatory cells in the airways in COPD. R O'Donnell D Breen S Wilson R Djukanovic, Thorax 2006 61 448 454 10.1136/thx.2004.024463 16648353